We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,660

Malaria Viagra unhappy ending for parasites
  • Watermark Patent & Trade Marks Attorneys
  • Australia
  • May 20 2015

A recent study has shown that the active ingredient in Viagra (sildenafil) has the capacity to slow the spread of malaria parasites. The study


Beyond adoption: the role of intellectual property rights in emerging Australian agricultural biotechnology and GM crops
  • Fisher Adams Kelly
  • Australia
  • May 14 2015

With the recent launch of The Official Australian Reference Guide to Agricultural Biotechnology and GM Crops, the Agricultural Biotechnology Council


Australian High Court confirms that late applications for pharmaceutical patent term extensions may be granted in Australia
  • DLA Piper LLP
  • Australia
  • May 6 2015

Pharmaceutical patent term extension regimes are of critical importance to innovators in the pharmaceutical industry, for whom an ability to exploit


A myriad of problems and opportunities a comparison of the patentability of isolated nucleic acid in the United States and Australia
  • DLA Piper LLP
  • Australia, USA
  • May 6 2015

Due to the inherent nature of the technologies that underpin it, the biotechnology industry has faced challenges worldwide in relation to precisely


Could the courts compel prescribers and dispensers of medicines to help big pharma fight generics?
  • Watermark Patent & Trade Marks Attorneys
  • Australia, United Kingdom
  • May 6 2015

A recent UK court ruling broke new ground in ordering an official health body to issue guidelines on prescribing a generic drug. Could the same thing


Patenting natural and organic cosmetics...can it be done?
  • Freehills Patent Attorneys
  • Australia
  • May 4 2015

Two interesting trends are occurring in the international cosmetics market which, at first glance, seem to be in conflict. The first trend is the


Costs of patent amendment application not immutable; opponent ordered to pay substantial legal costs
  • Davies Collison Cave
  • Australia
  • May 4 2015

Departing from the near 'immutable rule' that the amending party pay any other party's legal costs of the amendment


Federal Court awards additional damages for patent infringement for the first time
  • Davies Collison Cave
  • Australia
  • April 30 2015

The Federal Court has awarded additional damages under section 122(1A) of the Patents Act 1990 (Cth) as well as substantial compensatory


Damages recovery by the Commonwealth pursuant to the “usual undertakings”
  • Davies Collison Cave
  • Australia
  • April 29 2015

A recent procedural decision by Nicholas J in the Federal Court provides an interesting snapshot of the issues involved in the recovery of damages by


Omnibus claims revisited - not quite dead yet!
  • Spruson & Ferguson
  • Australia
  • April 28 2015

Omnibus claims are claims which refer directly to the specification andor drawings of an application. These are commonly of the form "A product or